Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 4/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 4/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 6/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | PPARA | Q07869 | 1/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6661533 | 0.94 | CYP4F2 (0.46) | CYP4F2CYP4A11POLBGAANPSR1 | |
| SCHEMBL19367022 | 0.92 | CYP4F2 (0.46) | CYP4F2CYP4A11POLBGAANPSR1 | |
| SCHEMBL12285235 | 0.89 | CYP4F2 (0.34) | CYP4F2CYP4A11POLBGAANPSR1 | |
| SCHEMBL1803764 | 0.89 | POLB (0.39) | POLBGAANPSR1TDP1ALDH1A1 | |
| SCHEMBL37083 | 0.89 | POLB (0.39) | CYP4F2CYP4A11POLBGAANPSR1 | |
| SCHEMBL1198114 | 0.86 | TSHR (0.38) | CYP4F2CYP4A11POLBGAANPSR1 | |
| Ethylene Glycol SCHEMBL830063 | 0.86 | POLB (0.38) | CYP4F2CYP4A11POLBGAANPSR1 | |
| SCHEMBL28902649 | 0.86 | NAAA (0.40) | POLBGAANPSR1ACHETDP1 | |
| SCHEMBL651971 | 0.86 | NAAA (0.40) | POLBGAANPSR1ACHETDP1 | |
| Bromide SCHEMBL16048766 | 0.84 | POLB (0.37) | CYP4F2CYP4A11POLBGAANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117321088-A | Preparation of monodisperse Polymer beads by Room temperature initiation | 深圳华大基因科技有限公司 | 2023-12-29 | — | — | CN | claimed |
| WO-2022218327-A1 | PREPARATION OF MONODISPERSE POLYMER BEADS WITH ROOM TEMPERATURE INITIATION METHODS | BGI SHENZHEN CO., LTD. (CN) | 2022-10-20 | — | — | WO | claimed |
| US-20250034027-A1 | METHOD FOR PREPARING GLASS NANOSTRUCTURES AND NANOSTRUCTURED SUBSTRATES THEREOF | CORNING INCORPORATED | 2025-01-30 | — | — | US | disclosed |
| US-20240279377-A1 | PREPARATION OF MONODISPERSE POLYMER BEADS WITH ROOM TEMPERATURE INITIATION METHODS | BGI SHENZHEN CO., LTD. (CN) | 2024-08-22 | — | — | US | disclosed |
| CN-117321088-A | Preparation of monodisperse Polymer beads by Room temperature initiation | 深圳华大基因科技有限公司 | 2023-12-29 | — | — | CN | disclosed |
| WO-2022218327-A1 | PREPARATION OF MONODISPERSE POLYMER BEADS WITH ROOM TEMPERATURE INITIATION METHODS | BGI SHENZHEN CO., LTD. (CN) | 2022-10-20 | — | — | WO | disclosed |
| US-20120059173-A1 | DENDRITIC MOLECULES | THE UNIVERSITY OF QUEENSLAND (AU) | 2012-03-08 | — | — | US | disclosed |
| US-20120059173-A1 | DENDRITIC MOLECULES | THE UNIVERSITY OF QUEENSLAND (AU) | 2012-03-08 | — | — | US | disclosed |
| US-20120059173-A1 | DENDRITIC MOLECULES | THE UNIVERSITY OF QUEENSLAND (AU) | 2012-03-08 | — | — | US | disclosed |
| EP-2147042-A1 | DENDRITIC MOLECULES | The University Of Queensland (AU) | 2010-01-27 | — | — | EP | disclosed |
| WO-2008141357-A1 | DENDRITIC MOLECULES | THE UNIVERSITY OF QUEENSLAND (AU) | 2008-11-27 | — | — | WO | disclosed |
| WO-2008141357-A1 | DENDRITIC MOLECULES | THE UNIVERSITY OF QUEENSLAND (AU) | 2008-11-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059173-A1 | DENDRITIC MOLECULES | CD40LG, CD40, TLR3 | CYP4F2 4548/4885CYP4A11 4627/4885POLB 3171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.